Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
J Exp Clin Cancer Res ; 24(2): 209-15, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16110753

RESUMEN

The aim of the present study was to validate low dose Multislice Spiral Computed Tomography (MSCT) in the diagnosis of breast lesions. Fourteen patients with mammographic and ultrasound findings suspect of malignant neoplasm underwent dynamic MSCT of the breast under basal conditions and 1, 3, and 6 minutes after intravenous injection of iodinated contrast medium. Both enhancement of the lesion >100% without further increase after 6 minutes, and irregular margins of the lesion were considered signs of malignancy. All lesions were examined cytologically and/or histologically. A correct diagnosis was achieved by MSCT in 7/8 malignant lesions, and in 6/6 benign lesions. The only malignant lesion missed by MSCT was histologically a ductal carcinoma in situ (false negative). In one case the MSCT showed the multifocality of an infiltrating ductal carcinoma, and in another it defined the bilaterality of the malignant lesions. Sensitivity and specificity of MSCT in the diagnosis of malignancy of a lesion were 88% and 100%, respectively. Our results suggest that MSCT is an effective diagnostic method to define suspicious breast lesions, and a valid alternative to Magnetic Resonance Imaging, especially when the latter is not feasible.


Asunto(s)
Neoplasias de la Mama/diagnóstico , Carcinoma Ductal de Mama/diagnóstico , Mamografía/métodos , Tomografía Computarizada Espiral/métodos , Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/diagnóstico por imagen , Carcinoma Ductal de Mama/patología , Medios de Contraste/administración & dosificación , Femenino , Humanos , Radioisótopos de Yodo/administración & dosificación , Sensibilidad y Especificidad , Factores de Tiempo
2.
G Chir ; 25(1-2): 43-6, 2004.
Artículo en Italiano | MEDLINE | ID: mdl-15112761

RESUMEN

The association between chemotherapy and hypertermia produces a synergic effect. In this study the Authors present their experience, by the analysis of the results. From 1993 to 2000, 17 patients have been treated with surgery associated with hypertermic chemotherapy for peritoneal carcinomatosis. For the management of these patients a constant cooperation among surgeon, cardiologist and anaesthetist is very important.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Carcinoma/secundario , Enfermedades Cardiovasculares/etiología , Hipertermia Inducida/efectos adversos , Neoplasias Peritoneales/secundario , Adulto , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias del Apéndice/patología , Neoplasias de la Mama/cirugía , Tumor Carcinoide/secundario , Carcinoma/tratamiento farmacológico , Carcinoma/cirugía , Carcinoma/terapia , Carcinoma Ductal de Mama/cirugía , Enfermedades Cardiovasculares/fisiopatología , Cisplatino/administración & dosificación , Cisplatino/efectos adversos , Neoplasias del Colon/patología , Terapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Siembra Neoplásica , Neoplasias Primarias Secundarias , Neoplasias Ováricas/patología , Neoplasias Peritoneales/tratamiento farmacológico , Neoplasias Peritoneales/cirugía , Neoplasias Peritoneales/terapia , Estudios Retrospectivos , Neoplasias Gástricas/patología , Resultado del Tratamiento
4.
Clin Ter ; 154(4): 245-50, 2003.
Artículo en Italiano | MEDLINE | ID: mdl-14618941

RESUMEN

MRI is a multiparametric, multiplanar, non-invasive largely employed tool for assessing osseous, ligamentous and tendineous injuries, inflammatory and degenerative changes of the knee. Although its wider availability and the lack of ionizing radiations MRI should be used only if clinically useful in patient management, in a appropriate diagnostic iter including plain film and/or ultrasound examination. The aim of our work is to review possibilities, limits and current indications for MRI assessment of diseases of the knee.


Asunto(s)
Rodilla/patología , Imagen por Resonancia Magnética , Humanos , Cápsula Articular/patología , Artropatías/patología , Traumatismos de la Rodilla/patología
6.
J Exp Clin Cancer Res ; 22(1): 35-9, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12725320

RESUMEN

The aim of the present study was to assess the role of virtual cystoscopy in the identification of bladder tumors. Fifteen patients (11 men and 4 women, median age: 61 years, range: 46-74 years) with a positive finding of bladder tumor at fiber-optic cystoscopy were studied by multislice-CT. Scans were downloaded to a workstation with the aid of a software for the processing of 3-D reconstructions, with a volume-rendering technique which allowed the "navigation" within the bladder in search of wall lesions. In this group of 15 patients, cystoscopy was able to detect 19 neoplastic lesions, 13 with a diameter >10 mm and 6 with a diameter <10 mm. Virtual cystoscopy, instead, identified 17 lesions (89%) only. In particular, all those lesions with a diameter >1 cm (13/13=100%) were correctly identified, whereas only 4 of the 6 lesions with a diameter <1 cm were depicted. The 2 false negative cases were 2 lesions with a flat morphology, measuring 5 and 6 mm. Most recent technological advances allowed the employement of virtual endoscopies, characterized by the absence of invasivity as compared with fiber-optic studies and based on data obtained by spiral- and multislice-CTs. According to our experience, virtual CT-cystoscopy revealed to be a complementary tool in the evaluation of cross-sectional images and proved to be an easy procedure without complications, well-accepted by the patients, and with a reliable detection of those bladder lesions measuring more than 5 mm in case of polypoid formations and at least 10 mm in case of flat lesions. This technique, however, does not allow the collection of a bioptic sample and--with the present resolution power of available equipments--it could be unable to correctly detect small-sized flat lesions. We, nonetheless, believe that this procedure, in the future, thanks to rapid technological improvements in virtual imaging techniques, could become a useful diagnostic tool in the management of those patients with bladder tumors. Further studies on larger study groups are therefore desirable for a more reliable validation of the technique.


Asunto(s)
Tomografía Computarizada por Rayos X/métodos , Neoplasias de la Vejiga Urinaria/diagnóstico por imagen , Anciano , Cistoscopía/métodos , Femenino , Tecnología de Fibra Óptica , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Persona de Mediana Edad , Fibras Ópticas , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Neoplasias de la Vejiga Urinaria/patología
7.
Clin Ter ; 153(5): 347-9, 2002.
Artículo en Italiano | MEDLINE | ID: mdl-12510421

RESUMEN

Esthesioneuroblastoma, also known as olfactory neuroblastoma, is a rare neuroendocrine tumor originating from the olfactory epithelium of the upper nasal cavity and representing < 3% of all tumors of the nasal cavities. This malignant tumor is characterized by a slow growth and local recurrencies and has a more favorable prognosis as compared with other more frequent forms of neuroblastomas originating from the suprarenal medulla and the sympathetic nervous system. Affected patients usually present with a history of progressive nasal obstruction, rhinorrhea, and severe epistaxis--sign of the conspicuous vascularity of this type of tumor. The combined use of CT and MR techniques allows the diagnostic suspicion of esthesioneuroblastoma and is of vital importance in the accurate staging of the disease and in the treatment planning.


Asunto(s)
Estesioneuroblastoma Olfatorio/diagnóstico por imagen , Imagen por Resonancia Magnética , Cavidad Nasal , Neoplasias Nasales/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad
8.
J Exp Clin Cancer Res ; 21(4): 613-6, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12636110

RESUMEN

Horseshoe kidney is a congenital anomaly of the upper urinary system frequently associated with atypical vascularization, mostly asymptomatic, usually undetected until the onset of infectious, obstructive or neoplastic complications. Although intravenous pyelography and US are useful tools, the role of CT is of vital importance especially in the pre-operative planning of related complications and in those cases where other techniques have correctly diagnosed the disease but have missed the visualization of an underlying malformation. We report here two cases of adenocarcinoma in two patients with a horseshoe kidney, where CT has clearly depicted both the malformation and the associated pathologic findings.


Asunto(s)
Adenocarcinoma/diagnóstico por imagen , Neoplasias Renales/diagnóstico por imagen , Riñón/anomalías , Adenocarcinoma/cirugía , Transformación Celular Neoplásica , Diagnóstico Diferencial , Humanos , Riñón/diagnóstico por imagen , Riñón/patología , Neoplasias Renales/cirugía , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
9.
Radiol Med ; 101(5): 321-5, 2001 May.
Artículo en Italiano | MEDLINE | ID: mdl-11438782

RESUMEN

AIM: The aim of this study was to evaluate the readability of radiologic reports and to determine whether they can be improved by modifying then according to precisely defined rules. MATERIAL AND METHODS: Forty reports, 10 for each diagnostic procedure (conventional radiography, US, CT, MRI); were randomly selected from a corpus of 400. The reports were analysed quantitatively using a dedicated software and qualitatively taking into account the formal, syntactic and lexical aspects of linguistically correct language and specially defined rules. On the basis of the collected results the reports were modified and analysed. RESULTS: Once again the modifications resulted in increased legibility (as testified by readability indices) that was more evident in US and X-ray reports and less evident in CT and MR reports because of the quantity of technical terms. It hoped that a radiological lexicon and guidelines for report writing will be widely adapted, so that radiologic reports will be more readable and easy understand.


Asunto(s)
Registros Médicos/normas , Radiografía , Escritura/normas , Humanos , Lectura
11.
Aliment Pharmacol Ther ; 14(5): 625-34, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10792127

RESUMEN

BACKGROUND: The effects of H. pylori eradication on atrophic body gastritis are controversial. AIM: To investigate the effect of triple therapy on atrophic body gastritis in H. pylori-positive patients and its effect on morpho-functional gastric parameters. METHODS: Thirty-five consecutive atrophic body gastritis patients with histological/serological evidence of H. pylori infection were treated. Before and 6 and 12 months after H. pylori eradication the patients were evaluated for fasting gastrinemia and pepsinogen I, basal and peak acid output, and detailed histological assessment including the ECL cell proliferative patterns. RESULTS: Six months after treatment, 25 out of 32 patients were cured (78%). Cure of infection was associated with improvement in both basal (basal acid output mean 0.23 +/- 0.14 mmol/h vs. 1.75 +/- 0.7 mmol/h, P < 0.005) and stimulated acid secretion (peak acid output mean 3.0 +/- 1.06 mmol/h vs. 16.6 +/- 4.1 mmol/h, P=0.0017) as well as with reduction in hypergastrinemia (mean gastrin levels 444.1 +/- 110.7 pg/mL vs. 85.3. +/- 28 pg/mL; P < 0.005). In contrast, the eradication had no effect on body corporal atrophy and intestinal metaplasia, or pepsinogen I levels (mean 16.6 +/- 2.9 ng/mL vs. 14.2 +/- 2.1 ng/mL, N.S.). These results were confirmed at 12 months after eradication. A statistical inverse correlation was obtained (r=-0.3635, P < 0.05) between the corporal chronic infiltrate score and peak acid output values. A total of 53% of atrophic body gastritis patients showed a regression in severity of body ECL cell hyperplastic change. CONCLUSION: Cure of H. pylori infection in patients with atrophic gastritis reverses some adverse effects on gastric function and ECL cell hyperplasia. H. pylori infection may be cured in atrophic body gastritis patients with partial reversion of its negative consequences on acid secretion and body ECL cell hyperplasia.


Asunto(s)
Células Enterocromafines/patología , Mucosa Gástrica/patología , Gastrinas/sangre , Gastritis Atrófica/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Adulto , Anciano , Femenino , Gastritis Atrófica/patología , Humanos , Hiperplasia , Masculino , Persona de Mediana Edad , Pepsinógeno A/sangre , Pepsinógeno A/metabolismo , Estudios Prospectivos , Resultado del Tratamiento
12.
Hum Pathol ; 31(2): 140-8, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10685627

RESUMEN

To ascertain the frequency and the clinico-functional correlations of intramucosal cysts in the gastric body of patients with the Zollinger-Ellison syndrome (ZES) and to clarify the relevant mechanism of development, a total of 106 consecutive ZES patients (58 M, 48 F; mean age: 53 yrs, range 19-93 yrs) were investigated with a mean of 7.2 biopsy specimens of the body mucosa per patient proved to be suitable for the study. Biopsies of endoscopically detectable polypoid lesions were not considered. Cystic changes were evaluated with respect to their severity by assessing the cyst grade (0, absent, 1; <30%, 2; 30-60%; 3 >60% of the mucosal area of the biopsy specimen of individual patients showing the most pronounced finding, respectively) and to their intragastric distribution by assessing the ratio of biopsy specimens showing cystic changes over the total number of biopsies examined in each patient. Intramucosal cysts were found in biopsies of non-polypoid gastric body mucosa in 71.7% of 106 patients with Zollinger-Ellison syndrome (ZES) and showed grade 2 and 3 severity in 22 and 8 cases, respectively. The severity of cystic changes correlated with the gastrin levels (p = 0.0005) and was more advanced in patients with active than in those with cured disease (p = 0.037). In the former group, furthermore, advanced cystic changes correlated with age (p = 0.03), male gender (p = 0.014), years of disease from onset (p < 0.02), years of omeprazole treatment (p = 0.033), basal acid output (p < 0.02), severity of ECL cell proliferative changes (p = 0.028), and absence of previous gastrinoma resection (p = 0.039) whereas they did not correlate with MEN-1 status, gastritis, maximal acid output, total duration of any antisecretory drug treatment, daily doses of omeprazole (> 20 mg vs 20 mg), years from surgery, duodenal localization of gastrinoma(s), presence of gastric carcinoid tumor(s) and of liver metastases. In groups of patients subdivided according to three levels of serum gastrin, the duration of omeprazole treatment was not related to the severity of cystic changes. It is concluded that intramucosal cysts in non polypoid gastric body mucosa of ZES patients are by far more common than the already reported fundic gland polyps, to which they likely give raise. Circulating levels of gastrin have an important independent role in their development.


Asunto(s)
Quistes/etiología , Mucosa Gástrica/patología , Estómago/patología , Síndrome de Zollinger-Ellison/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento , Biopsia , División Celular , Quistes/epidemiología , Quistes/patología , Células Enterocromafines/patología , Femenino , Ácido Gástrico/metabolismo , Gastrinoma , Gastrinas/sangre , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/uso terapéutico , Caracteres Sexuales , Neoplasias Gástricas , Síndrome de Zollinger-Ellison/patología
13.
Am J Gastroenterol ; 94(3): 766-72, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10086664

RESUMEN

OBJECTIVE: Atrophic body gastritis (ABG) is characterized by atrophy of the gastric body mucosa, hypergastrinemia, and hypo/achlorhydria. Its association with pernicious anemia is well recognized. Gastric hypo/achlorhydria is known to affect iron absorption but ABG is rarely considered as a possible cause of iron deficiency (microcytic) anemia. The aims of this study were to validate a screening methodology for the detection of ABG in a consecutive series of patients with microcytic and macrocytic anemia and to investigate the clinical and gastric morphofunctional characteristics of the two hematological presentations of ABG. METHODS: A two-part prospective study was carried out. Part A aimed to validate the screening methodology to detect the presence of ABG in patients with macrocytic and microcytic anemia who have no specific GI symptoms, by measuring their gastrin levels and verified by performing gastroscopy with biopsy. Part B aimed to detect the presence of ABG in a larger sample of anemic patients by our validated method and, by pooling the data of ABG patients, to determine the clinical, gastric histological, and functional characteristics pertaining to the macrocytic and microcytic presentations of ABG. RESULTS: In part A, ABG was detected in 37.5% of patients with macrocytic and in 19.5% of those with microcytic anemia. Pooling the data of the ABG patients from part A and part B, microcytic ABG patients were on average 20 yr younger than those with macrocytic anemia. The majority of microcytic ABG patients were female, most of whom were premenopausal. H. pylori infection was widely represented in the microcytic ABG group (61.1%). They also had a lesser grade of body mucosal atrophy and lower hypergastrinemia levels, suggesting a less severe oxyntic damage of shorter duration. CONCLUSIONS: Macrocytic anemia is not the only hematological presentation of ABG. Physicians evaluating patients with unexplained iron deficiency anemia should consider ABG as a possible cause by determining fasting gastrin levels and performing gastroscopy with biopsies of the body mucosa.


Asunto(s)
Anemia Ferropénica/complicaciones , Anemia Macrocítica/complicaciones , Gastritis Atrófica/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Anemia Ferropénica/diagnóstico , Anemia Macrocítica/diagnóstico , Femenino , Gastritis Atrófica/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos
14.
J Pathol ; 185(4): 389-93, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9828837

RESUMEN

The alpha-subunit of human chorionic gonadotropin (hCG-alpha) has previously been found to be expressed in hyperplasias and tumours of numerous endocrine tissues including all those involved in MEN-I syndrome except the parathyroid glands. In the present immunohistochemical investigation of 86 patients with various states of hyperparathyroidism, expression of hCG-alpha by subsets of parathyroid cells was shown in 46 cases (54 per cent) including all states of hyperparathyroidism investigated: primary adenoma (n = 34, 44 per cent); uraemic secondary hyperplasia (n = 34, 53 per cent); MEN-I (n = 13, 77 per cent); MEN-II (n = 2, 100 per cent); and parathyroid carcinoma (n = 3, 100 per cent). Although the number of parathyroid cells expressing hCG-alpha was in general low, the occurrence of numerous immunoreactive cells appeared to be concentrated in primary adenoma and MEN-I (20 and 33 per cent of positive cases, respectively). No expression was found in ten normal control glands, except for very rare cells in one case. Expression of hCG-alpha was in part associated with that of hCG-beta, which appeared to be more commonly expressed than hCG-alpha in cases of secondary hyperparathyroidism. In separate experiments, Bouin fixation was found to preserve the immunoreactivity of hCG-alpha and hCG-beta better than the formalin fixation used in this study, suggesting that the figures may be underestimates. These immunohistochemical results are in agreement with a previous biochemical study showing hCG-alpha and hCG-beta in extracts of parathyroid tumours and extend to the parathyroid glands the otherwise ubiquitous finding of hCG-alpha expression in MEN-I-related neoplasms.


Asunto(s)
Gonadotropina Coriónica Humana de Subunidad beta/metabolismo , Hormonas Glicoproteicas de Subunidad alfa/metabolismo , Hiperparatiroidismo/metabolismo , Glándulas Paratiroides/metabolismo , Adenoma/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hiperparatiroidismo/patología , Hiperparatiroidismo Secundario/metabolismo , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Neoplasia Endocrina Múltiple/metabolismo , Proteínas de Neoplasias/metabolismo , Neoplasias de las Paratiroides/metabolismo , Estudios Retrospectivos , Uremia/metabolismo
15.
Aliment Pharmacol Ther ; 12(8): 779-88, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9726392

RESUMEN

BACKGROUND: Acid hypersecretion is associated with duodenal ulcer disease in the following conditions: Zollinger-Ellison syndrome (ZES) and antral gastrin cell hyperfunction (AGCH) due to hypergastrinaemia, or hypersecretory duodenal ulcer (HDU) without hypergastrinaemia. AIM: To evaluate whether quantitative changes in fundic ECL and D cells may be involved in acid hypersecretion. PATIENTS AND METHODS: Seven ZES, six AGCH and six HDU Helicobacter pylori-positive patients were compared. Basal (BAO) and pentagastrin-stimulated gastric acid secretions (PAO), and morphometry of fundic ECL and D cells were performed. The six AGCH and six HDU patients were investigated again using the same tests 1 year after H. pylori eradication. RESULTS: Median PAO values were no different in all the hypersecretory conditions studied. The median volume density of ECL cells in ZES was significantly higher than in controls (2.75, range 1.74-5.8 vs. 0.73, 0.52-1.11: P < 0.05), whereas it was in the control range in AGCH and HDU patients (0.77, range 0.20-1.39 and 0.99, range 0.42-1.51; respectively). The count of fundic D cells was significantly lower in AGCH patients than in all other investigated groups (median 0.16, range 0.1-0.52; P < 0.05). Cure of infection in AGCH and HDU patients did not modify the ECL cell volume density, whereas a significant increase in the count of fundic D cells was observed in AGCH patients. Thus, the ECL/D cell index was significantly affected in AGCH patients (P < 0.05), being higher during H. pylori infection (median 6, range 0.7-9.25) than after the cure (median 2.12, range 1.10-3.5). BAO and PAO were not affected by H. pylori eradication in either group. CONCLUSIONS: The study provides evidence, for the first time, that quantitative alterations in the fundic endocrine cells are not involved in acid hypersecretion of patients with hypersecretory states, and that eradication of H. pylori does not restore normal acid secretion values.


Asunto(s)
Úlcera Duodenal/fisiopatología , Ácido Gástrico/metabolismo , Fundus Gástrico/fisiología , Helicobacter pylori/fisiología , Síndrome de Zollinger-Ellison/fisiopatología , Adulto , Úlcera Duodenal/microbiología , Femenino , Fundus Gástrico/citología , Células Secretoras de Gastrina/fisiología , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Pentagastrina/farmacología
16.
Verh Dtsch Ges Pathol ; 81: 103-10, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9474860

RESUMEN

Neuroendocrine proliferation of gastric mucosa is commonly encontered in routine gastric biopsies and is an indirect effect of modern drugs suppressing acid secretion. The process is virtually circumscribed to the ECL cell, the most common endocrine cell of the oxyntic mucosa, and is dependent on the trophic effect of the concomitant hypergastrinemia in most cases. It starts in the form of hyperplastic lesions that in some cases evolves into dysplasia and neoplasia. Gastrin has promoting but not transforming properties for such ECL cell tumour induction. Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha. Gastric neuroendocrine tumours independent of the trophic effect of gastrin are less frequent but more malignant. Their pathogenesis and precursor lesions are ignored.


Asunto(s)
Mucosa Gástrica/patología , Sistemas Neurosecretores/patología , Proteínas Proto-Oncogénicas , Neoplasias Gástricas/genética , Neoplasias Gástricas/patología , Tumor Carcinoide/genética , Tumor Carcinoide/patología , División Celular/efectos de los fármacos , Mapeo Cromosómico , Cromosomas Humanos Par 11 , Genes Supresores de Tumor , Sustancias de Crecimiento/farmacología , Humanos , Proteínas de Neoplasias/genética , Células Parietales Gástricas/patología , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA